{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:22:09Z","timestamp":1792034529380,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jsps.2023.101848","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:51:54Z","timestamp":1698216714000},"page":"101848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prescription patterns of quetiapine for multiple drug abuse, depression, and psychosis: A retrospective study"],"prefix":"10.1007","volume":"31","author":[{"given":"Ayman M.","family":"Al-Qaaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama S.","family":"Al-Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan A.","family":"Musharraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumanah S.","family":"AlSaedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana L.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed J.","family":"Aldhafiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.jsps.2023.101848_b0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/ph14020156","article-title":"Quetiapine-induced place preference in mice: Possible dopaminergic pathway","volume":"14","author":"Althobaiti","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.jsps.2023.101848_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13214","article-title":"Combined effects of quetiapine and opioids: A study of autopsy cases, drug users and sedation in rats","volume":"27","author":"Andersen","year":"2022","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jsps.2023.101848_b0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncir.2013.00152","article-title":"Dopamine signaling in reward-related behaviors","volume":"7","author":"Baik","year":"2013","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.jsps.2023.101848_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.753845","article-title":"Prescription pattern and off-label use of antipsychotics in a middle eastern population","volume":"12","author":"Bastaki","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsps.2023.101848_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20130709-01","article-title":"Efficacy of quetiapine off-label uses: data synthesis","volume":"51","author":"Carney","year":"2013","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"issue":"7","key":"10.1016\/j.jsps.2023.101848_b0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jsps.2023.101848_b0035","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1345\/aph.1Q697","article-title":"Safety of low doses of quetiapine when used for insomnia","volume":"46","author":"Coe","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"5","key":"10.1016\/j.jsps.2023.101848_b0040","first-page":"388","article-title":"Quetiapine abuse and dependence in psychiatric patients: A systematic review of 25 case reports in the literature","volume":"19","author":"Cuba\u0142a","year":"2013","journal-title":"J. Subst. Abus."},{"key":"10.1016\/j.jsps.2023.101848_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp-rj.2022.180207","article-title":"A brief review of quetiapine","volume":"18","author":"Curry","year":"2022","journal-title":"American Journal of Psychiatry Residents' Journal."},{"key":"10.1016\/j.jsps.2023.101848_b0050","article-title":"Comparison of quetiapine abuse and misuse reports to the FDA adverse event reporting system with other second-generation antipsychotics","volume":"13","author":"Evoy","year":"2019","journal-title":"Subst Abuse."},{"key":"10.1016\/j.jsps.2023.101848_b0055","first-page":"268","article-title":"Atypicality of atypical antipsychotics","volume":"7","author":"Farah","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry."},{"key":"10.1016\/j.jsps.2023.101848_b0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/10550490802266185","article-title":"Low-dose quetiapine is not a benign sedative-hypnotic agent","volume":"17","author":"Gugger","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jsps.2023.101848_b0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2146\/ajhp070112","article-title":"Quetiapine: treatment for substance abuse and drug of abuse","volume":"65","author":"Hanley","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jsps.2023.101848_b0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1176\/appi.ajp.162.9.1755-a","article-title":"Intravenous quetiapine abuse","volume":"162","author":"Hussain","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jsps.2023.101848_b0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/DHPS.S296515","article-title":"Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers","volume":"13","author":"Jahnsen","year":"2021","journal-title":"Drug Healthc Patient Saf."},{"key":"10.1016\/j.jsps.2023.101848_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2019.03.078","article-title":"Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment","volume":"251","author":"Javdan","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jsps.2023.101848_b0085","doi-asserted-by":"crossref","first-page":"29374.1","DOI":"10.32598\/ijmtfm.v10i4.29374","article-title":"The effects of quetiapine on craving and withdrawal symptoms in methamphetamine abuse: A randomized, double-blind, placebo-controlled trial","volume":"10","author":"Javdan","year":"2020","journal-title":"International Journal of Medical Toxicology and Forensic Medicine."},{"issue":"1","key":"10.1016\/j.jsps.2023.101848_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2279-042X.200987","article-title":"Quetiapine misuse and abuse: Is it an atypical paradigm of drug seeking behavior?","volume":"6","author":"Kim","year":"2017","journal-title":"J Res Pharm Pract."},{"key":"10.1016\/j.jsps.2023.101848_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5811\/westjem.2016.10.32322","article-title":"Intentional recreational abuse of quetiapine compared to other second-generation antipsychotics","volume":"18","author":"Klein","year":"2017","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jsps.2023.101848_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ADM.0000000000000020","article-title":"Evaluation of quetiapine abuse and misuse reported to poison centers","volume":"8","author":"Klein-Schwartz","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.jsps.2023.101848_b0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2018.03.002","article-title":"Increasing rates of quetiapine overdose, misuse, and mortality in Victoria","volume":"187","author":"Lee","year":"2018","journal-title":"Australia. Drug Alcohol Depend."},{"key":"10.1016\/j.jsps.2023.101848_b0110","first-page":"39","article-title":"Emergency department visits involving misuse and abuse of the antipsychotic quetiapine: Results from the drug abuse warning network (DAWN)","volume":"9","author":"Mattson","year":"2015","journal-title":"Subst Abuse."},{"key":"10.1016\/j.jsps.2023.101848_b0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3949\/ccjm.88a.20031","article-title":"Quetiapine for primary insomnia: Consider the risks","volume":"88","author":"Modesto-Lowe","year":"2021","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jsps.2023.101848_b0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/7854_2015_424","article-title":"Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics","volume":"34","author":"Montebello","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"9","key":"10.1016\/j.jsps.2023.101848_b0125","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1176\/appi.ajp.161.9.1718","article-title":"Intranasal quetiapine abuse","volume":"161","author":"Pierre","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jsps.2023.101848_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12740\/PP\/32923","article-title":"Misuse and abuse of quetiapine","volume":"49","author":"Pir\u00f3g-Balcerzak","year":"2015","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.jsps.2023.101848_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1078345811421591","article-title":"Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison","volume":"18","author":"Reeves","year":"2012","journal-title":"J. Correct. Health Care"},{"issue":"4","key":"10.1016\/j.jsps.2023.101848_b0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00702-018-1957-2","article-title":"Dopamine and addiction: what have we learned from 40 years of research","volume":"126","author":"Solinas","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jsps.2023.101848_b0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1517\/14740330802496883","article-title":"Is quetiapine a drug of abuse? Reexamining the issue of addiction","volume":"7","author":"Tcheremissine","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.jsps.2023.101848_b0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/10826084.2019.1668013","article-title":"Quetiapine abuse fourteen years later: Where are we now? A systematic review","volume":"55","author":"Vento","year":"2020","journal-title":"Subst Use Misuse."},{"issue":"1","key":"10.1016\/j.jsps.2023.101848_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.2007.164.1.173a","article-title":"Intravenous quetiapine-cocaine use (\u201cQ-ball\u201d)","volume":"164","author":"Waters","year":"2007","journal-title":"Am. J. Psychiatry"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:11Z","timestamp":1736184551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1319016423003432"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101848","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription patterns of quetiapine for multiple drug abuse, depression, and psychosis: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101848"}}